A γ-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice

Cancer Prevention Research

Volumn 2, Issue 2, 2009, Pages 143-152

  Ju, Jihyeung ^a   Hao, Xingpei ^a   Lee, Mao Jung ^a   Lambert, Joshua D ^a   Lu, Gang ^a   Xiao, Hang ^a   Newmark, Harold L ^a   Yang, Chung S ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTANE; ALPHA TOCOPHEROL; AZOXYMETHANE; DELTA TOCOPHEROL; DEXTRAN SULFATE; DRINKING WATER; GAMMA TOCOPHEROL; LEUKOTRIENE B4; PROSTAGLANDIN E2; REACTIVE NITROGEN SPECIES; 3-NITROTYROSINE; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; ANTIOXIDANT; CARCINOGEN; DRUG DERIVATIVE; PROSTAGLANDIN F2 ALPHA; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CARCINOGENESIS; COLITIS; COLON ADENOCARCINOMA; COLON ADENOMA; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG MECHANISM; IMMUNOHISTOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; ADENOCARCINOMA; ADENOMA; ANIMAL; BLOOD; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; COCARCINOGENESIS; COLON; COLON TUMOR; DOSE RESPONSE; INFLAMMATION; METABOLISM; PATHOLOGY;

ADENOCARCINOMA; ADENOMA; ANIMALS; ANTIOXIDANTS; APOPTOSIS; AZOXYMETHANE; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; COCARCINOGENESIS; COLON; COLONIC NEOPLASMS; DEXTRAN SULFATE; DINOPROST; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-TOCOPHEROL; INFLAMMATION; LEUKOTRIENE B4; MALE; MICE; TYROSINE;

EID: 63249095069     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0099     Document Type: Article

References (59)

1. Traber MG. Vitamin E. Baltimore (MD): Lippincott Williams and Wilkins; 2006.
2. Hensley K, Benaksas EJ, Bolli R, et al. New perspectives on vitamin E: γ-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine. Free Radic Biol Med 2004;36:1-15. (Pubitemid 38068287)
3. Eitenmiller T, Lee J. Vitamin E: food chemistry, composition, and analysis. New York: Marcel Dekker, Inc.; 2004.
4. U.S. Department of Commerce and U.S. Bureau of the Census. Fat and oils: production, consumption, and stocks 2004; 2005.
5. Dietrich M, Traber MG, Jacques PF, Cross CE, Hu Y, Block G. Does γ-tocopherol play a role in the primary prevention of heart disease and cancer? A review. J Am Coll Nutr 2006;25:292-299 (Pubitemid 44414696)
6. Reiter E, Jiang Q, Christen S. Anti-inflammatory properties of a- and g-tocopherol. Mol Aspects Med 2007;5-6:668-691
7. Liu M, Wallmon A, Olsson-Mortlock C, Wallin R, Saldeen T. Mixed tocopherols inhibit platelet aggregation in humans: potential mechanisms. Am J Clin Nutr 2003;77:700-706 (Pubitemid 36258583)
8. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. Jama 2005;294:56-65. (Pubitemid 41002839)
9. Bairati I, Meyer F, Gelinas M, et al. A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst 2005;97:481-488 (Pubitemid 40590429)
10. Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol 2003;157:335-344 (Pubitemid 36193936)
11. Gann PH, Ma J, Giovannucci E, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 1999;59:1225-1230 (Pubitemid 29136251)
12. Nomura AM, Stemmermann GN, Lee J, Craft NE. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 1997;6:487-491 (Pubitemid 27295226)
13. Yong LC, Brown CC, Schatzkin A, et al. Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic follow-up study. First National Health and Nutrition Examination Survey. Am J Epidemiol 1997;146:231-243
14. O'Leary KA, de Pascual-Tereasa S, Needs PW, Bao YP, O'Brien NM, Williamson G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat Res 2004;551:245-254 (Pubitemid 38833512)
15. Jiang Q, Elson-Schwab I, Courtemanche C, Ames BN. γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proc Natl Acad Sci U S A 2000;97:11494-11499 (Pubitemid 30780923)
16. Jiang Q, Ames BN γ-Tocopherol, but not α-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats. FASEB J 2003;17:816-822
17. Jiang Q, Wong J, Fyrst H, Saba JD, Ames BN. γ-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis. Proc Natl Acad Sci U S A 2004;101:17825-17830 (Pubitemid 40051971)
18. Jiang Q, Lykkesfeldt J, Shigenaga MK, Shigeno ET, Christen S, Ames BN. γ-Tocopherol supplementation inhibits protein nitration and ascorbate oxidation in rats with inflammation. Free Radic Biol Med 2002;33:1534-1542 (Pubitemid 35351597)
19. De Pascale MC, Bassi AM, Patrone V, Villacorta L, Azzi A, Zingg JM. Increased expression of transglutaminase-1 and PPARγ after vitamin E treatment in human keratinocytes. Arch Biochem Biophys 2006;447:97-106.
20. Campbell SE, Stone WL, Whaley SG, Qui M, Krishnan K. Gamma (γ) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (γ) expression in SW 480 human colon cancer cell lines. BMC Cancer 2003;3:25. (Pubitemid 38851324)
21. Campbell SE, Stone WL, Lee S, et al. Comparative effects of RRR-α- and RRR-γ-tocopherol on proliferation and apoptosis in human colon cancer cell lines. BMC Cancer 2006;6:13. (Pubitemid 43298461)
22. Yu W. Evaluation of the anticancer actions of natural vitamin E forms RRR-α-tocopherol and γ-tocopherol. Abstract for poster #68 at the ACS International Research Conference on Food, Nutrition and Cancer, Washington, DC, July 13-14, 2006; 2006.
23. Gysin R, Azzi A, Visarius T. γ-Tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins. FASEB J 2002;16:1952-1954
24. Jiang Q, Wong J, Ames BN. γ-Tocopherol induces apoptosis in androgen-responsive LNCaP prostate cancer cells via caspase-dependent and independent mechanisms. Ann N Y Acad Sci 2004;1031:399-400. (Pubitemid 40361789)
25. Reddy BS, Tanaka T. Interactions of selenium deficiency, vitamin E, polyunsaturated fat, and saturated fat on azoxymethane-induced colon carcinogenesis in male F344 rats. J Natl Cancer Inst 1986;76:1157-1162 (Pubitemid 16093151)
26. Chester JF, Gaissert HA, Ross JS, Malt RA, Weitzman SA. Augmentation of 1,2-dimethylhydrazine-induced colon cancer by experimental colitis in mice: role of dietary vitamin E. J Natl Cancer Inst 1986;76:939-942
27. Temple NJ, el-Khatib SM. Cabbage and vitamin E: their effect on colon tumor formation in mice. Cancer Lett 1987;35:71-77
28. Yao K, Latta M, Bird RP Modulation of colonic aberrant crypt foci and proliferative indexes in colon and prostate glands of rats by vitamin E. Nutr Cancer 1996;26:99-109. (Pubitemid 26266736)
29. Maziere S, Meflah K, Tavan E, Champ M, Narbonne JF, Cassand P. Effect of resistant starch and/or fat-soluble vitamins A and E on the initiation stage of aberrant crypts in rat colon. Nutr Cancer 1998;31:168-177
30. Hagiwara A, Boonyaphiphat P, Tanaka H, et al. Organ-dependent modifying effects of caffeine, and two naturally occurring antioxidants α-tocopherol and n-tritriacontane-16,18-dione, on 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP)-induced mammary and colonic carcinogenesis in female F344 rats. Jpn J Cancer Res 1999;90:399-405.
31. Chung H, Wu D, Han SN, et al. Vitamin E supplementation does not alter azoxymethane-induced colonic aberrant crypt foci formation in young or old mice. J Nutr 2003;133:528-532 (Pubitemid 36172911)
32. Exon JH, South EH, Taruscio TG, Clifton GD, Fariss MW. Chemopreventive effect of dietary d-α-tocopheryl succinate supplementation on precancer colon aberrant crypt formation and vitamin E analogue levels in young and old rats. Nutr Cancer 2004;49:72-80.
33. Cook MG, McNamara P. Effect of dietary vitamin E on dimethylhydrazine- induced colonic tumors in mice. Cancer Res 1980;40:1329-1331 (Pubitemid 10135852)
34. Toth B, Patil K. Enhancing effect of vitamin E on murine intestinal tumorigenesis by 1,2-dimethylhydrazine dihydrochloride. J Natl Cancer Inst 1983;70:1107-1111
35. Hirose M, Nishikawa A, Shibutani M, Imai T, Shirai T. Chemoprevention of heterocyclic amine-induced mammary carcinogenesis in rats. Environ Mol Mutagen 2002;39:271-278 (Pubitemid 34260502)
36. Dias MF, Sousa E, Cabrita S, Patricio J, Oliveira CF. Chemoprevention of DMBA-induced mammary tumors in rats by a combined regimen of α-tocopherol, selenium, and ascorbic acid. Breast J 2000;6:14-19 (Pubitemid 30204684)
37. Hirose M, Takahashi S, Ogawa K, Futakuchi M, Shirai T. Phenolics: blocking agents for heterocyclic amine-induced carcinogenesis. Food Chem Toxicol 1999;37:985-992 (Pubitemid 29481802)
38. Gould MN, Haag JD, Kennan WS, Tanner MA, Elson CE. A comparison of tocopherol and tocotrienol for the chemoprevention of chemically induced rat mammary tumors. Am J Clin Nutr 1991;53:1068-70S.
39. Newmark HL, Huang MT, Reddy BS. Mixed tocopherols inhibit azoxymethane-induced aberrant crypt foci in rats. Nutr Cancer 2006;56:82-85
40. Suh N, Paul S, Lee HJ, et al. Mixed tocopherols inhibit N-methyl-N-nitrosourea-induced mammary tumor growth in rats. Nutr Cancer 2007;59:76-81. (Pubitemid 47549784)
41. Seril DN, Liao J, Ho KL, Warsi A, Yang CS, Yang GY. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice.. Dig Dis Sci 2002;47:1266-1278 (Pubitemid 34606629)
42. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003;94:965-973 (Pubitemid 37508979)
43. Ward JM. Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab Invest 1974;30:505-513
44. Pascal RR. Dysplasia and early carcinoma in inflammatory bowel disease and colorectal adenomas. Hum Pathol 1994;25:1160-1171
45. Seril DN, Liao J, Ho KL, Yang CS, Yang GY. Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine. Carcinogenesis 2002;23:993-1001. (Pubitemid 34752955)
46. Suzuki R, Kohno H, Sugie S, Tanaka T. Sequential observations on the occurrence of preneoplastic and neoplastic lesions in mouse colon treated with azoxymethane and dextran sodium sulfate. Cancer Sci 2004;95:721-727 (Pubitemid 39335091)
47. Hao X, Sun Y, Yang CS, et al. Inhibition of intestinal tumorigenesis in Apc(min/+) mice by green tea polyphenols (polyphenon E) and individual catechins. Nutr Cancer 2007;59:62-69 (Pubitemid 47549782)
48. Miller KW, Yang CS. An isocratic high-performance liquid chromatography method for the simultaneous analysis of plasma retinol, α-tocopherol, and various carotenoids. Anal Biochem 1985;145:21-26
49. Ju J, Liu Y, Hong J, Huang MT, Conney AH, Yang CS. Effects of green tea and high-fat diet on arachidonic acid metabolism and aberrant crypt foci formation in an azoxymethane-induced colon carcinogenesis mouse model. Nutr Cancer 2003;46:172-178 (Pubitemid 37500509)
50. Kitchens, U. Exploring statistics, a modern introduction to data analysis and inference. Books/Cole Publishing Company. p. 122-30..
51. Suzuki R, Kohno H, Sugie S, Nakagama H, Tanaka T. Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis 2006;27:162-169 (Pubitemid 43025257)
52. Kohno H, Suzuki R, Sugie S, Tanaka T. Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer 2005;5:46. (Pubitemid 41461083)
53. Traber MG, Kayden HJ. Preferential incorporation of α-tocopherol vs γ-tocopherol in human lipoproteins. Am J Clin Nutr 1989;49:517-526
54. Vacchiano CA, Tempel GE. Role of nonenzymatically generated prostanoid, 8-iso-PGF2 α, in pulmonary oxygen toxicity. J Appl Physiol 1994;77:2912-2917
55. Morrow JD, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995;332:1198-1203
56. Cooney RV, Franke AA, Harwood PJ, Hatch-Pigott V, Custer LJ, Mordan LJ γ-Tocopherol detoxification of nitrogen dioxide: superiority to α-tocopherol. Proc Natl Acad Sci U S A 1993;90:1771-1775
57. 2 and their formation in rat insulinoma (RINm5F) cells. Free Radic Biol Med 1995;19:259-269
58. Christen S, Woodall AA, Shigenaga MK, Southwell-Keely PT, Duncan MW, Ames BN. γ-Tocopherol traps mutagenic electrophiles such as NO(X) and complements α-tocopherol: physiological implications. Proc Natl Acad Sci U S A 1997;94:3217-3222
59. Hoglen NC, Waller SC, Sipes IG, Liebler DC. Reactions of peroxynitrite with γ-tocopherol. Chem Res Toxicol 1997;10:401-407